Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Cancer and Metastasis Reviews
Metadata
Title
The type-1 insulin-like growth factor receptor tyrosine kinase and breast cancer: Biology and therapeutic relevance
Authors
Jennifer M. Gross
Douglas Yee
Publication date
01-12-2003
Publisher
Kluwer Academic Publishers
Published in
Cancer and Metastasis Reviews / Issue 4/2003
Print ISSN: 0167-7659
Electronic ISSN: 1573-7233
DOI
https://doi.org/10.1023/A:1023720928680

Other articles of this Issue 4/2003

Cancer and Metastasis Reviews 4/2003 Go to the issue

OriginalPaper

Jak family of kinases in cancer

OriginalPaper

Intraperitoneal cancer dissemination: Mechanisms of the patterns of spread

OriginalPaper

The role of integrin-linked kinase (ILK) in cancer progression

Editorial Introduction

Guest Editor

OriginalPaper

The Aurora kinases: Role in cell transformation and tumorigenesis

OriginalPaper

Src family kinases in tumor progression and metastasis
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits